相约星期六

战锤：全面战争2 40k：Gamescom 2026 首次上手前瞻_我的网站

一 |     预览核心要点：背景设定跨越到了遥远的未来采用了全新的 WarCore 游戏引擎单位自定义功能的加入令人欣喜，尽管目前还比较基础自从 Creative Assembly 在 2016 年发布第一部 战锤：全面战争2 以来，社区中对未来题材感兴趣的玩家就一直渴望能有一款以这款老牌桌面微缩模型系列第 41 个千年为背景的作品。虽然等待的时间比人们预想的要长，但 战锤：全面战争2 40k 已近在咫尺。    Global consulting giant McKinsey & Company advised several painkillers producers for 15 years on how to "turbocharge" prescription drug sales largely to blame for starting the opioid epidemic in the US, The New York Times has revealed citing over 100,000 documents.,The docs emerged as a part of a settlement deal that McKinsey signed with several state attorneys that sued the company.,Apart from working with Endo, Purdue, and Mallinckrodt, the company also provided "in-depth experience in narcotics" for Johnson & Johnson subsidiaries producing controlled substances. Meanwhile, hundreds of thousands of US citizens died from overdose, often linked to these very drugs.,How It All Started,According to the disclosed documents, McKinsey helped both Endo and Purdue, the creators of two of the most widespread opioid-based drugs for severe chronic pain, to launch their products Opana and OxyContin in 2006-2008. The firm even advised one of the companies on how to overcome a Food and Drug Administration (FDA) block which it had encountered in 2008.,The FDA blocked Purdue's attempt to release an upgraded version of its OxyContin, which was more difficult to snort or dilute and inject in bloodstream – two methods of the prescription drug's abuse that already had been devised by some of its recipients. In order to help Purdue get the license, McKinsey interviewed an ex-drug dealer on the medication's abuse, prepared docs and even coached the drug firm's officials for meetings with the FDA as the pharmaceutical company knew its drug had been widely abused, the docs suggest.,Crack Pipes: Biden Administration's Handling of US Opioid Crisis Raising Questions, Journo Says15 February, 13:00 GMT,Purdue's main competitor, Endo, also released a new version of its painkiller and tried to get it marked as resistant to crushing (for snorting) and diluting (for injections), but the FDA did not allow the latter citing lack of such properties. Nonetheless, the drug's release was a success and coincided with a drop in abuse-resistant OxyContin's sales.,This came, however, at a cost of local epidemics of previously unseen blood disorders in several US states in 2012 – patients were found to be anemic and suffered from kidney failure. Many of them admitted to abusing updated Opana – the new formulae indeed discouraged from snorting it, but still allowed injection abuse. However, the same component that prevented crushing took a great toll on those who tried to inject the drug to get a better high, leading to red blood cells' destruction and organ damage.,Going on the 'Offensive',The consulting company's involvement in the opioid crisis did not stop at helping the companies to launch their products – it also helped them to boost the sales.,While the pills like the ones produced by Endo, Purdue and Mallinckrodt were originally advertised as not causing additions, US doctors were not always prone to prescribing them, especially when a patient's pain was neither severe nor chronic. According to the revealed documents, McKinsey's consultants helped Purdue, and several other companies, including two J&J subsidiaries, to overcome this "problem".,Starting in 2009, McKinsey developed a "segmentation" strategy for Purdue: its analysts divided the company's customers into groups based on their potential thoughts of the product and then formed distinct messages for each group. The customers in this case were doctors prescribing painkillers and the product was opioid drugs. The strategy targeted even doctors who resorted to opioids only in most extreme cases, ensuring them of OxyContin's safety and trying to convince them that there was no point in making their patients suffer.,The consulting company proposed to achieve this by "[raising] physician comfort levels through appropriate education and support". Purdue tried to convince these doctors that their colleagues had no issues prescribing OxyContin.,By 2014, the US government started to realize a nascent opioid drug problem was underway and introduced new labeling requirements for such drugs as well as instructions to use them only in cases of severe of chronic pain. Around the same time, OxyContin sales started to decline, prompting Purdue to ask for McKinsey's help once again – this time to overcome the government's policy and precautions.,The consultants identified the problem as the company promoting its drug as a less potent opioid amid rampant drug abuse and advised to shift to the "offense" instead, the documents show. They namely advised focusing the salesmen efforts on doctors, who were likely to prescribe OxyContin to a new client not previously taking opioid drugs.,"Physicians with higher OxyContin NBRx to Rx ratio may be more likely to initiate a patient on OxyContin", an extract from a McKinsey presentation for Purdue from January 2014 said.,Around the same time and amid the 2015 HIV concentrated outbreaks in several states linked to the opioid drugs abuse via injections, McKinsey consulted Endo on promoting its Opana. The company was not concerned about what the CDC named "explosive transmission" of HIV and the Opana's role in it, according to the documents. On the contrary, in summer 2015, it helped Endo rededicate most of its salesmen from other products into a "Sales Force Blitz" – the company almost solely dedicated to selling Opana to around 3,000 physicians in the US.,One of McKinsey's consultants was excited over the creation of the "Force", claiming in correspondence with the head of Endo’s painkiller unit that the "fun [begins] on Monday!" with the latter responding "agreed, the fun is just beginning".,Playing Both Sides,One of the strangest revelations in the documents uncovered by the New York Times is that McKinsey managed to play both sides of the opioid crisis tragedy – helping pharmaceutical companies sell more of "not-so-addiction-resistant" drugs, while also assisting the FDA, other government agencies and state governments, in the fight against the epidemic.,In 2017, the FDA finally decided to pull one of the drugs, the more potent Opana, from the market, but not until it made $844 million in revenue with help from McKinsey and played a role in the deaths of thousands of Americans, considered to be the victims of the opioid epidemic. Paradoxically, the same year, McKinsey Senior Partner Tom Latkovic lamented about doctors prescribing opioid painkillers left and right at a health care conference.,"Why do we continue to prescribe, dispense, pay for opioid prescriptions to people that we know, or at least we could know, have an incredibly high propensity to abuse them?" Latkovic wondered.,The bizarre divergence between what McKinsey was advising to the pharmaceutical companies and Latkovic's rhetoric is explained by the fact that he was not a member of the consulting company's pharmaceutical practice, which worked with pharma.,Instead, he and his team worked with state governments and health systems to pin down the ways of tackling the opioid crisis, The New York Times said citing two local officials, who used to work on the issue. Their work, however, was partly complicated by McKinsey's pharmaceutical wing, which wanted to greenlight their draft publications in case they could damage their clients.,North Carolina Rep. Claims Opioid Crisis 'Affects Every Community' in US Amid Drug Trafficking Surge19 December 2021, 01:36 GMT,Eventually in 2019, McKinsey finally stopped advising its top client, Perdue, but not until their ties became public during one of the litigations related to the opioid epidemic and initiated by US authorities. One such litigation eventually had McKinsey pay $600 million in settlement without admitting guilt, as well as release the documents related to its work with the pharmaceutical companies.。

二 | 在最近的一次活动中，我有幸试玩了这款战略续作的早期版本，肃清了一些残暴的欧克兽人，并传播帝皇的圣言。我体验的版本包含三个重点部分：教程、战役玩法的预览（包括一些自定义内容），以及最后的一场大规模战役——所有这些都是通过星际战士的视角展开的。

三 | 总而言之，那是约一小时充满爆炸、子弹和士兵们高喊“为了帝皇！”的体验。在此之前，Total War 系列虽然也有远程单位，但核心一直是两军对垒，用剑等冷兵器近身肉搏。

四 | 本作不仅是 Creative Assembly 全新引擎 WarCore 的首次亮相，也是这一长寿系列中首款以远程战斗为核心的作品。投石机退场，坦克和步行机甲登场。

五 | 随着时间跨越到第 41 个千年，游戏玩法本身也不得不随之进化。通过教程，我对这个备受喜爱的系列在全新的严酷黑暗设定下如何运作有了基础的了解。我的小队被派去守卫坠机现场，这让我快速掌握了移动、寻找掩体，以及向绿皮降下导弹雨等更有趣的操作。这也是一个开始掌握玩家在正式发售后必须精通的新机制的好机会，例如侧移射击、火力压制以及从轨道召唤空投舱补充兵力。也许我最喜欢的一点是，画面中完全看不到弹药条。

六 | 感谢帝皇。即便装备了大量枪械，你也不必担心 40k 会失去激烈的近战肉搏，这部分依然存在。当我暂停动作并缩放视角观察星际战士与欧克兽人的大规模血战时，新 WarCore 引擎的优势体现得最为明显：可以看到各种单位身上沾满鲜血，或者正在翻越掩体。

七 | 看着星际战士的链锯剑及其动力齿轮在欧克兽人的斧头上火花四溅，同时子弹在头顶穿梭，这景象确实令人叹为观止。虽然这一新作显然寻求改变，但 战锤：全面战争2 40k 骨子里依然是一款 Total War 游戏，拥有该系列赖以成名的战术深度和战略沙盒。即使在入门关卡中，庞大的战斗人数和需要管理的多条战线也让我时刻保持警惕。

八 | 定位和反制敌人仍然是核心考量，而新作似乎提供了更多征服战场并根据需求扭转局势的方法。

九 | 由于我有一段时间没玩 Total War 系列了，在战役任务的一个紧张时刻，我重新领悟到了这些战术要点。该任务要求我收复附近的 Theta-Citadel 星语中继站，并清除异形威胁——又是欧克兽人。

十 | 它们的太空部队已经就位，不仅在地面，还在轨道上对星球进行破坏。在降落到地面之前，我想先观察一下星际战士所处的星系。行星围绕着一颗令人不安的血红色恒星运行，附近还有一个同样威严的混沌之门在隐隐作现。在演示版中我无法与它们互动或利用它们，这只是对未来机制的预告。缩放回到我任务所在的星球，我看到了熟悉的 Total War 界面，包括各个区域、城市和可指挥的军队。我可以轻松旋转视角查看星球的大片区域以寻找目标，而背景中弯曲地平线外的太空景象很好地衬托出了本作的宏大规模。在训练了一些新部队并前往车站后，是时候让我自定义的“德摩斯不灭者”战团（我在任务前设置并涂装的自定义战团）去对付 Snaz Braggerz 并肃清要塞了。我部署了侵略者小队、仲裁者、无畏机甲、冲击者处决者坦克等单位，将它们编组并派往前线。由于我的一些糟糕决策（提醒自己：不要把兵力分散得太薄，而且在情况变得棘手时别忘了把游戏速度调回来），欧克兽人迅速开始向我最后一组陆战队和坦克推进。在战斗前期，我曾让这组部队在附近降落场的制高点固守。经过几分钟紧张的交火和从轨道舰船召唤的火力支援，我们终于击溃了欧克兽人，并摧毁了它们的史考帕超重型步行机。看着这个黄色怪物倾倒并爆炸，其成就感几乎不亚于我在玩 40k 实体棋子时的体验。人类帝国再次获得了胜利！不幸的是，这种成就感和膨胀的自信带我直接进入了 Creative Assembly 留给我们的“极难”大决战，只能说结果不尽如人意……刚才，你可能注意到我提到了“德摩斯不灭者”，这是我在任务前涂装的自定义星际战士战团。自定义是 40k 乃至整个微缩模型游戏的重要组成部分，所以我很高兴在战役演示的一开始就能预览这方面的功能。

十一 | 对于那些从未涉足桌面微缩模型领域的人来说，通常你带到桌上的军队必须先组装，而且通常也都是未上色的。“灰模山”是爱好者们的一个戏称，用来指代那些积压在手里还没上色和自定义的模型。

十二 | 诚然，现阶段提供的选项还有点欠缺，除了自定义战团名称和徽章外，只能调整基础色、强调色和细节色，并应用到整套盔甲上。不过，可选颜色的数量相当可观，Creative Assembly 使用了 Games Workshop 发布的实际油漆颜色。在选项中，我看到了熟悉的 Caledor Sky 和 Screamer Pink，最后选择了 Mournfang Brown 作为我“德摩斯不灭者”的基础色。现场代表明确表示，在 战锤：全面战争2 40k 最终发售时，会有更多选项和细节供玩家探索。

十三 | 作为一个拥有一大堆灰色未上色单位的人（我发誓它们都上过底漆了！），我希望其中一个选项能让我把军队做成那种标志性的塑料感。在严肃对待这件事的同时，我确实希望自定义功能提供足够的灵活性，让现实中的 40k 玩家能在这里重现他们的自定义涂装。我不只是想玩星际战士，我想指挥“我的”星际战士。Total War 的核心基因目前看来依然完整。在经历了 战锤：全面战争2 III 和 2023 年 全面战争：法老 关于 DLC 处理的各种问题和失误后，Creative Assembly 团队在 战锤：全面战争2 40k 上有很多东西需要证明。我在预览活动中所看到的展现了潜力；既然社区一直有此诉求，我希望他们能够不负众望。

十四 | 战锤：全面战争2 40k 距离发售还有一段路要走，目前尚未设定发布窗口。

十五 | 我们还没看到灵族（Aeldari）阵营的踪影，到目前为止，我们也只是窥见了 Creative Assembly 为这款最新战术巨作投入的深度。Total War 的核心基因目前看来依然完整，但我们仍需拭目以待，看看更侧重远程战斗的风格和其他 40k 元素的影响，最终会造就一个真正特别的作品，还是一个堕落于混沌的产物。近期其他大作预览：战争机器：事变日漫威金刚狼The Duskbloods。

Current article:http://shs62t.senbatuqiuzhuanlanrilao.sbs/oh7h/20260826/5222512.html

Published on:22:36:31